Cardiac Amyloidosis: From Early Diagnosis to New Therapeutic Frontiers

ABC HF invites the entire scientific community to contribute to its new thematic call, under the guest editorship of Prof. Fabio Fernandes, Dr. Edileide de Barros Correia, and Prof. Marcus Vinicius Simões, coordinated by Editor-in-Chief Prof. Germano Emílio Conceição Souza.

Cardiac amyloidosis is undergoing an unprecedented transformation: advances in cardiovascular imaging and intelligent screening are shortening the path to diagnosis, while disease-modifying therapies are changing the natural history of ATTR. Brazil, with its unique epidemiological profile and still underdiagnosed cases, has a strategic role in this agenda, and the national scientific production needs to be represented in this debate.

The call welcomes original articles (cross-sectional studies, prospective or retrospective cohorts, ecological/epidemiological studies, and clinical trials), case reports with relevant discussion, case series, systematic reviews, and meta-analyses, addressing early diagnosis and screening, multimodal cardiovascular imaging, diagnostic algorithms, differential diagnosis with similar conditions, genetics, disease-modifying therapies, as well as care organization and the patient journey.

Submissions will be open from September 23 to November 30, 2026, exclusively via ScholarOne. As the journal follows a continuous publication model, accepted articles will be published as soon as they are ready, identified with the thematic call label.

Manuscript Submission

To submit your manuscript, please visit: https://mc04.manuscriptcentral.com/abchf

Questions and Information

For further information or inquiries, please contact: abcheartfailure@cardiol.br

We appreciate your interest in contributing to this important collection!